UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 178

Sortiert nach

Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications

Frontiers in neurology, 2014-01, Vol.5, p.242-242

Cenci, M Angela

2014

Link zum Volltext

Verfügbarkeit prüfen

Animal models of l‐dopa‐induced dyskinesia in Parkinson's disease

Movement disorders, 2018-06, Vol.33 (6), p.889-899

2018

Link zum Volltext

Verfügbarkeit prüfen

M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia

Neuron (Cambridge, Mass.), 2015-11, Vol.88 (4), p.762-773

2015

Link zum Volltext

Verfügbarkeit prüfen

Dopamine dysregulation of movement control in l -DOPA-induced dyskinesia

Trends in neurosciences (Regular ed.), 2007-05, Vol.30 (5), p.236-243

Cenci, M. Angela

2007

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism

Brain (London, England : 1878), 2014-07, Vol.137 (Pt 7), p.1998-2014

2014

Link zum Volltext

Verfügbarkeit prüfen

Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia

Nature communications, 2014-10, Vol.5 (1), p.5316-5316, Article 5316

2014

Link zum Volltext

Verfügbarkeit prüfen

On the neuronal circuitry mediating l-DOPA-induced dyskinesia

Journal of Neural Transmission, 2018-08, Vol.125 (8), p.1157-1169

2018

Link zum Volltext

Verfügbarkeit prüfen

Post‐ versus presynaptic plasticity in L‐DOPA‐induced dyskinesia

Journal of neurochemistry, 2006-10, Vol.99 (2), p.381-392

2006

Link zum Volltext

Verfügbarkeit prüfen

Zooming in on the small: The plasticity of striatal dendritic spines in l-DOPA-Induced dyskinesia

Movement disorders, 2015-04, Vol.30 (4), p.484-493

2015

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of dopamine D1 receptor-mediated ERK1/2 activation in the parkinsonian striatum and their modulation by metabotropic glutamate receptor type 5

The Journal of neuroscience, 2014-03, Vol.34 (13), p.4728-4740

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signaling

The Journal of pharmacology and experimental therapeutics, 2009-07, Vol.330 (1), p.227

2009

Link zum Volltext

Verfügbarkeit prüfen

Levodopa-induced dyskinesia is strongly associated with resonant cortical oscillations

The Journal of neuroscience, 2012-11, Vol.32 (47), p.16541-16551

2012

Link zum Volltext

Verfügbarkeit prüfen

l-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia

Journal of neurochemistry, 2010-03, Vol.112 (6), p.1465-1476

2010

Link zum Volltext

Verfügbarkeit prüfen

Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease

Neurobiology of disease, 2011-06, Vol.42 (3), p.327-340

2011

Link zum Volltext

Verfügbarkeit prüfen

Validation of an improved scale for rating l -DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonists

Neurobiology of disease, 2016-12, Vol.96, p.156-170

2016

Link zum Volltext

Verfügbarkeit prüfen

Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia

Annals of neurology, 2010-11, Vol.68 (5), p.619-628

2010

Link zum Volltext

Verfügbarkeit prüfen

Dramatic differences in susceptibility to L -DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion

Neurobiology of disease, 2016-10, Vol.94, p.213-225

2016

Link zum Volltext

Verfügbarkeit prüfen

Non-Apoptotic Caspase-3 Activation Mediates Early Synaptic Dysfunction of Indirect Pathway Neurons in the Parkinsonian Striatum

International journal of molecular sciences, 2022-05, Vol.23 (10), p.5470

2022

Link zum Volltext

Verfügbarkeit prüfen

Posters presentation selected for the blue ribbon session at the annual meeting of the Parkinson's disease and movement disorders society (Hong Kong, October, 2018)

Movement disorders, 2018-12, Vol.33 (12), p.1977-1991

2018

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa—induced dyskinesia

Proceedings of the National Academy of Sciences - PNAS, 2010-12, Vol.107 (50), p.21824-21829

2010

Link zum Volltext

Verfügbarkeit prüfen

A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys

Neurobiology of disease, 2010-09, Vol.39 (3), p.352-361

2010

Link zum Volltext

Verfügbarkeit prüfen

Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia

Nature neuroscience, 2003-05, Vol.6 (5), p.501-506

2003

Link zum Volltext

Verfügbarkeit prüfen

Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia

Proceedings of the National Academy of Sciences - PNAS, 2014-03, Vol.111 (12), p.4578-4583

2014

Link zum Volltext

Verfügbarkeit prüfen

Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice

Current protocols in neuroscience, 2007-10, Vol.Chapter 9, p.Unit 9.25

2007

Link zum Volltext

Verfügbarkeit prüfen

Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: Effects of combined treatment and possible mechanisms of action

Experimental neurology, 2013-12, Vol.250, p.116-124

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 178

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(168)
Mit Volltextzugriff
(135)

Publikationsform

Sprache

Englisch
(178)
Japanisch
(49)

Erscheinungsjahr

n.n

Thema

Science & Technology
(141)
Life Sciences & Biomedicine
(135)
Neurosciences
(130)
Medical And Health Sciences
(121)
Medicin Och Hälsovetenskap
(121)
Neurosciences & Neurology
(120)
Animals
(117)
Basic Medicine
(91)
Medicinska Och Farmaceutiska Grundvetenskaper
(91)
Neurovetenskaper
(91)
Neurology
(71)
Parkinson's Disease
(64)
Rats
(60)
Disease Models, Animal
(58)
Humans
(54)
Clinical Neurology
(45)
Female
(45)
Levodopa - Adverse Effects
(41)
Rats, Sprague-Dawley
(39)
Biological And Medical Sciences
(34)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications

Animal models of l‐dopa‐induced dyskinesia in Parkinson's disease

M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia

Dopamine dysregulation of movement control in l -DOPA-induced dyskinesia

Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism

Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia

On the neuronal circuitry mediating l-DOPA-induced dyskinesia

Post‐ versus presynaptic plasticity in L‐DOPA‐induced dyskinesia

Zooming in on the small: The plasticity of striatal dendritic spines in l-DOPA-Induced dyskinesia

Mechanisms of dopamine D1 receptor-mediated ERK1/2 activation in the parkinsonian striatum and their modulation by metabotropic glutamate receptor type 5

Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signaling

Levodopa-induced dyskinesia is strongly associated with resonant cortical oscillations

l-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia

Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease

Validation of an improved scale for rating l -DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonists

Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia

Dramatic differences in susceptibility to L -DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion

Non-Apoptotic Caspase-3 Activation Mediates Early Synaptic Dysfunction of Indirect Pathway Neurons in the Parkinsonian Striatum

Posters presentation selected for the blue ribbon session at the annual meeting of the Parkinson's disease and movement disorders society (Hong Kong, October, 2018)

Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa—induced dyskinesia

A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys

Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia

Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia

Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice

Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: Effects of combined treatment and possible mechanisms of action

Suchergebnisse filtern